CytomX Therapeutics (CTMX) Goodwill (2014 - 2026)

CytomX Therapeutics (CTMX) posted Goodwill of $949000.0 for Q1 2026, little changed on a QoQ basis from $949000.0 in Q4 2025, and little changed year-over-year from $949000.0 in Q1 2025.

CytomX Therapeutics (CTMX) Goodwill (2014 - 2026) Analysis & Trends

CytomX Therapeutics' Goodwill history runs 13 years deep, the most recent figure standing at $949000.0 for Q1 2026.

  • Quarterly Goodwill changed 0.0% year-over-year to $949000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $949000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $949000.0, changed 0.0% from the prior year.
  • Goodwill was $949000.0 for Q1 2026 at CytomX Therapeutics, roughly flat from $949000.0 in the prior quarter.
  • Across five years, Goodwill topped out at $949000.0 in Q1 2022 and bottomed at $949000.0 in Q1 2022.
  • A 5-year average of $949000.0 and a median of $949000.0 in 2022 frame the typical range for Goodwill.
  • Peak annual rise in Goodwill reached 0.0% in 2022, while the deepest fall reached 0.0% in 2022.
  • CytomX Therapeutics' Goodwill stood at $949000.0 in 2022, then changed by 0.0% to $949000.0 in 2023, then changed by 0.0% to $949000.0 in 2024, then changed by 0.0% to $949000.0 in 2025, then changed by 0.0% to $949000.0 in 2026.
  • Business Quant data shows CTMX's Goodwill at $949000.0 in Q1 2026, $949000.0 in Q4 2025, and $949000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 CytomX Therapeutics 574.36 Mn 227.66 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 949,000.00
Dec 31, 2025 949,000.00
Sep 30, 2025 949,000.00
Jun 30, 2025 949,000.00
Mar 31, 2025 949,000.00
Dec 31, 2024 949,000.00
Sep 30, 2024 949,000.00
Jun 30, 2024 949,000.00
Mar 31, 2024 949,000.00
Dec 31, 2023 949,000.00
Sep 30, 2023 949,000.00
Jun 30, 2023 949,000.00
Mar 31, 2023 949,000.00
Dec 31, 2022 949,000.00
Sep 30, 2022 949,000.00
Jun 30, 2022 949,000.00
Mar 31, 2022 949,000.00
Dec 31, 2021 949,000.00
Sep 30, 2021 949,000.00
Jun 30, 2021 949,000.00